PMV PHARMACEUTICALS INC (PMVP) Stock Income Statement
NASDAQ:PMVP - Nasdaq - US69353Y1038 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 88.79M | 85.45M | 80.13M | 77.04M | 58.29M | |||
| Research and Development | 62.78M | 58.53M | 55.88M | 51.99M | 36.49M | |||
| Selling, General, and Administrative Expenses | 26.01M | 26.92M | 24.25M | 25.05M | 21.80M | |||
| Operating Income | -88.79M | -85.45M | -80.13M | -77.04M | -58.29M | |||
| Interest Income/Expense | 9.64M | 10.65M | 11.17M | 3.63M | 450.00K | |||
| Other Income/Expense | -19.00K | -16.00K | 3.00K | 90.00K | 20.00K | |||
| Income Before Taxes | -79.17M | -74.81M | -68.96M | -73.33M | -57.82M | |||
| Income Tax | -18.30M | -16.10M | 2.00K | -10.00K | 20.00K | |||
| Net Income | -60.88M | -58.71M | -68.96M | -73.32M | -57.85M | |||
| EBITDA | -87.97M | -84.30M | -78.88M | -76.72M | -57.98M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.18 | -1.14 | -1.44 | -1.61 | -1.28 | |||
| Non GAAP EPS | -1.18 | -1.14 | -1.45 | -1.62 | -1.28 | |||
| Statistics | ||||||||
All data in USD